Zacks.com announces the list of stocks featured in the Analyst Blog.
Every day the Zacks Equity Research analysts discuss the latest news and
events impacting stocks and the financial markets. Stocks recently
featured in the blog include: Newcastle Investment Corp. (NYSE: NCT),
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA),
Novatel Wireless (Nasdaq: NVTL),
LDS Solar (NYSE: LDK)
and Cymer, Inc. (Nasdaq: CYMI).
Get the most recent insight from Zacks Equity Research with the free
Profit from the Pros newsletter: http://at.zacks.com/?id=4579
Here are highlights from Wednesday’s
Analyst Blog:
Hold Newcastle for Yield Only
Shares of Newcastle Investment Corp. (NYSE: NCT)
have tumbled over the past year as the mortgage markets are still in
disarray. As expected, the company continued to take charges in the 1st
quarter due primarily to impairments on subprime loans. NCT continues to
sell assets, at losses, to pay down debt and shore up the balance sheet.
The quarterly payout was cut 65% to $0.25 per share, and the yield is
now 10%. We feel that the company has enough liquidity to remain
solvent, although we are changing our near-term recommendation to Hold.
Residential mortgage markets have not yet bottomed out and the liquidity
crisis is not over.
Pipeline a Bit Early on Alexza
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA)
focuses on the development and commercialization of proprietary products
for the treatment of acute and intermittent conditions. We are
enthusiastic on the company's proprietary novel Staccato system that
reformulates oral or injectable small molecule compounds into an
inhalable aerosol.
The company has six product candidates in clinical stage trials,
including leading candidates AZ-001 for migraine headache pain relief
and AZ-004 for acute agitation in patients with schizophrenia. Recent
data on both drugs lead us to believe the Staccato system is both safe
and highly effective.
Our price target is $8 and our rating is Hold. At this time, we think
investors can be patients with Alexza. Preliminary data on AZ-001 and
AZ-004 looks encouraging, but the company still has to complete phase
III trials before we proclaim either a success. Upside over the next few
quarters could come from the announcement on a partnership or the phase
II data on AZ-002.
Novatel a Hold on Competition
We maintain our Hold recommendation and the same valuation target for
Novatel Wireless (Nasdaq: NVTL),
a leading provider of wireless data access cards and embedded solutions,
following first quarter 2008 financial results. Lack of proper business
execution, delays in product shipment due to technical issues, and a
shift in market demand towards the company's low-end products, were
primary reasons sited for lackluster performance.
We believe these issues will continue to impact the company through the
remainder of this fiscal year, as Novatel did not provide any specific
time frame and visibility when opportunities from its new product-cycle
can be derived. In addition, the market for wireless data access
equipment has become more competitive as several large vendors are on
the verge of introducing innovative products with attractive pricing.
Margin Concerns for LDS Solar
LDS Solar's (NYSE: LDK)
revenue and earnings for the first quarter continued to show strong
growth, which again exceeded market expectations. We think LDK will
continue to grow quickly in the next few quarters due to its aggressive
capacity expansion and strong growth of solar power industry worldwide.
However, we are concerned its gross margin will continue to decline due
to rising pre-sold orders and increasing competition in the wafer
segment. In addition, it will take some time for investor confidence to
return. Therefore, we are maintaining our Hold rating on LDK.
Cymer Downgraded to a Hold
Cymer, Inc. (Nasdaq: CYMI)
dominates the market for DUV light sources contained within excimer
laser-based photolithography systems used in the production of
semiconductors. We feel growth in ArF Lithography will drive growth in
the second half of 2008.
However, competition in ArF [Argon Fluoride]
has intensified as Gigaphoton has just shipped its 100th ArF system and
probably now has a 40% market share. Consequently, we are downgrading
our rating on CYMI shares to a Hold, though keeping our target price at
$30.00, which corresponds to a 13.9x P/E.
The stock is currently trading at an 12.5x multiple of price to our 2009
earnings estimate (P/E). We do not anticipate any large changes in the
firm's dominant market position, however we expect Gigaphoton to take
market share in ArF until Cymer creates another technologically superior
product. The firm is in a cyclical industry that is currently in the
down portion of a cycle. However, advanced ArF products have ASPs [average
selling prices] holding strong.
Want more from Zacks Equity Research? Subscribe to the free Profit from
the Pros newsletter: http://at.zacks.com/?id=2649.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative
analysis to help investors know what stocks to buy and which to sell for
the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded
stocks. Our analysts are organized by industry which gives them keen
insights to developments that affect company profits and stock
performance. Recommendations and target prices are six-month time
horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of
the latest analysis from Zacks Equity Research. Subscribe to this free
newsletter today: http://at.zacks.com/?id=2677
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was
formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he
could find patterns in stock market data that would lead to superior
investment results. Amongst his many accomplishments was the formation
of his proprietary stock picking system; the Zacks Rank, which continues
to outperform the market by nearly a 3 to 1 margin. The best way to
unlock the profitable stock recommendations and market insights of Zacks
Investment Research is through our free daily email newsletter; Profit
from the Pros. In short, it's your steady flow of Profitable ideas
GUARANTEED to be worth your time! Register for your free subscription to
Profit from the Pros at http://at.zacks.com/?id=4580.
Visit http://www.zacks.com/performance
for information about the performance numbers displayed in this press
release.
Disclaimer: Past performance does not guarantee future results.
Investors should always research companies and securities before making
any investments. Nothing herein should be construed as an offer or
solicitation to buy or sell any security.
